Mentor Capital, Inc. (MNTR)

mentorMentor Capital, Inc is a publicly traded private equity firm that invests in and acquires medical and social cannabis companies. It provides passive equity funding to smaller companies, invests in shelf IPOs, and aims to provide public market access to founders and owners of small businesses.

According to the company’s website, it is authorized to raise USD 23 M from the public market. A cannabis company wanting to get public market funding may trade in 10% to 60% of its business with Mentor Capital. Through its investing approach and capital structure, Mentor is looking to deliver higher prices to company founders for smaller slices of their businesses.

Mentor Capital’s portfolio includes Nevada Cannabis Ventures, MicroCannaBiz, LLC, Bhang Financial, Bhang Medicinal Chocolate (though this company’s agreement with Mentor is in dispute), GW Pharmaceuticals (with the largest index holding), Brighter Day Health, Shaw Capital Management, and Waste Consolidators, Inc.

Though Mentor Capital reaches both the medical and recreational marijuana industries, it states that it prefers to focus on the medical aspect. The company has even invested in the cancer immunotherapy sector, but plans to completely shift to the cannabis sector eventually.

Founded in 1985, Mentor Capital was formerly the Main Street Athletic Clubs, a chain of gyms in California. It was reinvented as Mentor Capital, Inc in 2008, and started to make investments in the cancer sector. Mentor states that when this sector experienced a collapse, the company decided to switch to the cannabis space.

In the OTC markets, Mentor Capital, Inc trades under the symbol MNTR, with a market cap of USD 5.51 M. Its company leaders are Chester Billingsley, Founder, CEO, and President; Lori J. Stansfield, CFO; and James J. Blazeck, Director.


Yahoo! Finance: MNTR News

Latest Financial News for MNTR

Mentor Capital Reports 66% 2018 Revenue Increase in 10-K

SAN DIEGO, CA / ACCESSWIRE / March 29, 2019 / Mentor Capital, Inc. (MNTR) announced that it had filed its annual 10-K filing for the year December 31, 2018, with the Securities and Exchange Commission. The Company reports that for the year ended December 31, 2018 Mentor had revenues of $5,281,533 and gross profit of $1,582,599 with a resulting net loss attributable to Mentor of ($409,161) or (1.8 cents) per share. The Mentor Capital, Inc. parent company has no non-affiliate debt and collected a net payment of $1,758,949 on January 23, 2018 in satisfaction of the Company's judgment against Bhang Corporation.

Mentor Capital Turns Profitable on 26% Year on Year Revenue Gains

SAN DIEGO, CA / ACCESSWIRE / November 14, 2018 / Mentor Capital, Inc. (MNTR) announced that it had filed its quarterly 10-Q filing for the third quarter ended September 30, 2018, with the Securities and Exchange Commission. For the quarter ended September 30, 2018, Mentor had revenues of $1,031,622 and gross profit of $300,501 with a resulting net income attributable to Mentor of $77,224 or 0.3 cents per share. This is an improvement over the prior year quarter ended September 30, 2017 revenues of $815,102 and gross profit of $289,211, with a resulting net loss attributable to Mentor of ($285,796) or (1.3 cents) per share.

Mentor Capital to Present on the Cannabis Market Thursday, October 4, 2018 at 9:30 (PST) at the OTCQX Virtual Investor Conference

SAN DIEGO, CA / ACCESSWIRE / October 1, 2018 / Mentor Capital, Inc. (OTCQX: MNTR) announced today that it has been invited to present and answer investor questions at the OTCQX® Virtual Investor Conference ...

Mentor Capital Adds Three Cannabis Investments in Two Months

Mentor Capital, Inc. (MNTR) announced that its investment in G FarmaLabs Limited has increased to $2,700,000 following yesterday’s seventh investment tranche delivered to G Farma of $250,000 from Mentor for additional leased equipment and working capital. Nicole Gonzalez, Founder of G FarmaBrands, comments, “With financial backing from Mentor Capital, G FarmaLabs has hit its benchmarks on the way to building cannabis efficient facilities and production lines.” Ata Gonzalez, Co-Founder of G FarmaLabs concludes, “Chet provides both money and a wealth of knowledge. “Mentor Capital focuses new investment from shareholders and other investors on larger cannabis companies, like G Farma, that have the potential to go public and who may be incubated by Mentor along that path,” explained Mentor Capital, Inc. CEO, Chet Billingsley.

Mentor Capital Upgraded to OTCQX Best Market Today

Mentor Capital, Inc. (MNTR), an M&A and funding provider for the cannabis and medical marijuana sector, will start to trade on the OTCQX Best Market effective today. Mentor joins more than twenty companies during 2018 that have upgraded to OTCQX from the OTCQB® Venture Market, according to OTC Markets Group, Inc. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com as well as other popular financial websites. OTCQX is designed for established, investor-focused U.S. and international companies that have met high financial standards, are current in their financial reporting and have been sponsored by a professional third-party advisor.